Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer. [electronic resource]
- Cancer research and treatment Jan 2019
- 408-412 p. digital
Publication Type: Case Reports; Journal Article
2005-9256
10.4143/crt.2018.138 doi
Acrylamides Aniline Compounds Carcinoma, Non-Small-Cell Lung--drug therapy Drug Resistance, Neoplasm ErbB Receptors--genetics Female Gene Frequency Humans Lung Neoplasms--drug therapy Middle Aged Mutation Piperazines--therapeutic use Protein Kinase Inhibitors--therapeutic use Republic of Korea